ANAPAX

Welcome to the Brand page for “ANAPAX”, which is offered here for Pharmaceutical preparations for the diagnosis, treatment and prevention of transplant rejection and other autoimmune diseases including psoriasis, systemic lupus erythematosus, and rheumatoid arthritis;.

Its status is currently believed to be active. Its class is unavailable. “ANAPAX” is believed to be currently owned by “Protein Design Labs, Inc.”

Owner:
PROTEIN DESIGN LABS, INC.
Owner Details
Description:
Pharmaceutical preparations for the diagnosis, treatment and prevention of transplant rejection and other autoimmune diseases including psoriasis, systemic lupus erythematosus, and rheumatoid arthritis;
Categories: PHARMACEUTICAL PREPARATIONS DIAGNOSIS